The purpose of this study is to determine if the study drug called ALZ-801 is safe, if it is well tolerated, and if it is effective in treating AD. It is a twice a day oral medication that is taken with meals.
- Diagnosis of MCI due to AD or mild AD
- 50-80 years old in good health
- Has a trial partner to come to visits
Primary Investigator: Malgorzata Franczak, MD
Status: Currently Enrolling